Atorvastatin
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Atorvastatin is a high-intensity statin used to lower LDL cholesterol and reduce cardiovascular risk. It is one of the most widely prescribed medications worldwide for hyperlipidemia, atherosclerotic cardiovascular disease prevention, and familial hypercholesterolemia.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Atorvastatin is a high-intensity statin used to lower LDL cholesterol and reduce cardiovascular risk. NutriStack rates the supporting evidence as strong. Common adult dosing is 10–80 mg once daily (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete coq10. This profile indexes 13 sources.
The bottom line
Evidence rating strong. Most-documented uses: lowers ldl cholesterol by 39–60%, reduces risk of myocardial infarction and stroke, slows progression of atherosclerosis. 13 sources indexed (2017–2024), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol biosynthesis. This reduces intracellular cholesterol, upregulates LDL receptor expression on hepatocyte surfaces, and increases clearance of LDL-C from the bloodstream. Also reduces VLDL production and modestly raises HDL-C.1
Dosing & protocol.
Can be taken with or without food at any time of day; unlike some statins, does not require evening dosing due to its long half-life1
What it depletes.
Nutrients this medication can lower over time, and what to replace.
CoQ10
ModerateHMG-CoA reductase inhibition reduces mevalonate pathway flux, lowering endogenous CoQ10 synthesis alongside cholesterol synthesis.
Full safety detail.
Side effects
- Myalgia and muscle pain
- Elevated liver transaminases
- Gastrointestinal upset (nausea, diarrhea, constipation)
- Headache
- Rhabdomyolysis (rare but serious)
- New-onset diabetes (modest increased risk)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
8- 1Atorvastatin before percutaneous coronary intervention: A systematic review and meta-analysisPMIDGarcía-Campa M, Flores-Ramírez R, Rojo-Garza S, Carrizales-Sepúlveda EF et al. · PLoS One · 2024
Pretreatment with atorvastatin before PCI significantly reduced periprocedural myocardial infarction and cardiac enzyme elevation compared to control
- 2Efficacy and Safety of Atorvastatin for Chronic Subdural Hematoma: An Updated Systematic Review and Meta-AnalysisPMIDMonteiro GA, Queiroz TS, Gonçalves OR, Cavalcante-Neto JF et al. · World Neurosurgery · 2024
Atorvastatin showed potential benefit in reducing hematoma volume and improving neurological outcomes in chronic subdural hematoma patients, though larger RCTs are needed
- 3Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysisPMIDSingh H, Kaur S, Kaushal P et al. · Expert review of clinical pharmacology · 2024
Singh H, Kaur S, Kaushal P et al.. Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysis. Expert review of clinical pharmacology. 2024
- 4[Efficacy and safety of atorvastatin in major cardiovascular events: Meta-analysis]PMIDVillegas-Quintero VE, Rivas-Ruíz R, García-Rivero AA et al. · Revista medica del Instituto Mexicano del Seguro Social · 2023
Villegas-Quintero VE, Rivas-Ruíz R, García-Rivero AA et al.. [Efficacy and safety of atorvastatin in major cardiovascular events: Meta-analysis]. Revista medica del Instituto Mexicano del Seguro Social. 2023
- 5Impact of atorvastatin on erectile dysfunction: A meta-analysis and systematic reviewPMIDSu H, Lu Y, Ma C et al. · Andrologia · 2022
Su H, Lu Y, Ma C et al.. Impact of atorvastatin on erectile dysfunction: A meta-analysis and systematic review. Andrologia. 2022
- 6Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participantsPMIDYebyo HG, Aschmann HE, Kaufmann M, Puhan MA · American Heart Journal · 2019
Atorvastatin and rosuvastatin were among the most effective statins for reducing major cardiovascular events and all-cause mortality in primary prevention across 94,283 participants from randomized trials
- 7Association of SLCO1B1 Polymorphisms and Atorvastatin Safety and Efficacy: A Meta-analysisPMIDDu Y, Wang S, Chen Z et al. · Current pharmaceutical design · 2018
Du Y, Wang S, Chen Z et al.. Association of SLCO1B1 Polymorphisms and Atorvastatin Safety and Efficacy: A Meta-analysis. Current pharmaceutical design. 2018
- 8Effects of atorvastatin on chronic subdural hematoma: A systematic reviewPMIDQiu S, Zhuo W, Sun C et al. · Medicine · 2017
Qiu S, Zhuo W, Sun C et al.. Effects of atorvastatin on chronic subdural hematoma: A systematic review. Medicine. 2017
Reference material
5- 9Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994.Source linkedPMID
- 10LaRosa JC et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease (TNT trial). N Engl J Med. 2005.Source linkedPMID
- 11Cholesterol Treatment Trialists' Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis. Lancet. 2010.Source linkedPMID
- 12Zhang L, Zhang S, Yu Y et al.. Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol : A meta-analysis of trials with East Asian populations. Herz. 2020Source linkedPMID
- 13Jiang R, Zhao S, Wang R et al.. Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized ClinicalTrial. JAMA neurology. 2018Source linkedPMID
Common questions.
Quick answers about Atorvastatin, drawn from the data on this page.
What is Atorvastatin?
Atorvastatin is a high-intensity statin used to lower LDL cholesterol and reduce cardiovascular risk. It is one of the most widely prescribed medications worldwide for hyperlipidemia, atherosclerotic cardiovascular disease prevention, and familial hypercholesterolemia.
What is Atorvastatin used for?
Commonly cited benefits of Atorvastatin include: Lowers LDL cholesterol by 39–60%; Reduces risk of myocardial infarction and stroke; Slows progression of atherosclerosis; Reduces cardiovascular mortality in high-risk patients. NutriStack rates the overall evidence as strong.
What is a typical dose of Atorvastatin?
A typical adult dose of Atorvastatin is 10–80 mg once daily (as prescribed by your physician). The commonly recommended form is Oral tablet. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Atorvastatin?
Reported side effects include myalgia and muscle pain, elevated liver transaminases, gastrointestinal upset (nausea, diarrhea, constipation), headache, rhabdomyolysis (rare but serious), new-onset diabetes (modest increased risk). This is educational information; check with a healthcare professional before use.
How strong is the evidence for Atorvastatin?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Atorvastatin in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.